Clinical Trial Update: Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

View source ↗

Summary

This clinical trial update reports on a study evaluating plasma 5hmC DNA signatures as biomarkers for metastasis in colorectal and appendiceal cancers; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Cancer
• Colorectal Cancer

Snippet

Sponsor: University of Chicago | Conditions: Colorectal Cancer Stage IV, Colorectal Cancer Metastatic | Status: ACTIVE_NOT_RECRUITING